Interestingly, solid tumors like neuroendocrine tumors including small cell lung cancer of the lung or prostate and also hematologic malignancies are able to produce FGF23 and could lead to FGF23-related hypophosphatemia [59, 63]. This evidence concerns the gene FGF23 and hypophosphatemia.